INSTITUTO DE INVESTIGACIÓN, DESARROLLO E INNOVACIÓN EN BIOTECNOLOGÍA SANITARIA DE ELCHE

Committed to healthcare
biotechnology.

RESEARCH WITH A PURPOSE

IDiBE is the Institute of Research, Development, and Innovation in Healthcare Biotechnology in Elche (Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche). We carry out multidisciplinary research, translating our excellent scientific results into products and services for the benefit of society.

A MARKET-ORIENTED VISION

We seek to collaborate with hospitals, other research centers and enterprises in the field of Health Biotechnology to deliver high-quality products and technologies to the market. We are committed to serving society and becoming a reference Institute in the field of translational knowledge.

Announcements

RESEARCH

We are using our expertise and know-how to find real-world solutions to healthcare challenges.

FIND OUT WHAT WE ARE WORKING ON

SERVICES

We are putting out technology and knowledge at the service of society. Are you looking for high-value services or guidance for your R&D projects?

LEARN WHAT WE CAN DO FOR YOU

EDUCATION

Head start your scientific career and get hands-on experience in a unique environment.

LEARN MORE

SCIENCE OUTREACH

We are excited to share our latest innovations and discoveries with the world. Curious about what we are up to?

SEE OUR LATEST NEWS AND EVENTS

DIRECTOR’S FOREWORD

The Institute of Research, Development and Innovation in Healthcare Biotechnology of Elche (IDiBE) is a Research Institute of the University Miguel Hernández de Elche, located in the University Campus at Elche, occupying a 4,000 sq. m. of laboratory in the Torregaitán Building.

IDiBE arises from the transformation of the Institute of Molecular and Cellular Biology (IBMC), created by Prof. José Manuel González-Ros, who had the vision of building a multidisciplinary research institute in the University as a sagacious strategy to carry highly competitive and transferable research in the fields of Biotechnology and Biomedicine. This commitment to translational research has been a pivotal hallmark of the Institute since its foundation. As a result, the IDiBE has excelled in its scientific production as well as in the exploitation of the results generated by their members. Furthermore, the interest in transferring the scientific results to society has thrust entrepreneurial actions and the establishment of joint units with private enterprises and local hospitals.

Our previous success has been possible thanks to our philosophy of potentiating collaborations and sharing resources as a way to efficiently exploit the synergies and complementarities of our interdisciplinary team

Our research teams have been very active in securing funding from both governmental and private sources, publishing papers that are widely cited (70% in Q1), training young scientists with the highest scientific and ethical standards as recognized by the mention of excellence and national accreditation of our doctorate program by the Ministry of Education, and disseminating our activities and achievements to society. Notwithstanding, a major impact of the Institute has been:

  • The exploitation of innovative products generated from the research projects in the fields of nutraceuticals, cosmeceuticals, and biotechnology.
  • Having three INDs in clinical development to treat human diseases.
  • Creating 11 spin-off/start-up companies.

To reinforce our transferable and translational activities, the IDiBE has implemented several technological platforms, and organized its research in two core lines:

  • Molecular design and cell signaling.
  • Diagnostic, prognostic and molecular therapy.

Our previous success has been possible thanks to our philosophy of potentiating collaborations and sharing resources as a way to efficiently exploit the synergies and complementarities of our interdisciplinary team. In addition, we are complemented by highly prepared and greatly skilled technical and administrative personnel who pivotally contribute to assisting our researchers technically and administratively, allowing them to focus on accomplishing their scientific objectives.

Although we have walked a long and fruitful way, there is still plenty to accomplish for increasing the IDiBE international exposure and scientific distinction. The General Council has approved a Plan of Action (2019-2022) that establishes the objectives and milestones for the next 4 years, strengthening the original vision, and establishing as a central mission to consolidate our multidisciplinary program of research excellence in healthcare biotechnology, serving as a channel of innovation for the productive and service sectors of our society. For this purpose, we have reinforced our team and reorganized our structure aiming to facilitate the transferable activities, with the undoubtful commitment to become an Institute of research excellence in translational science.

Sincerely yours,

Prof. Antonio Ferrer-Montiel
Director IDiBE